AM-Pharma’s purpose is to save and improve the lives of patients confronted with severe medical conditions. Our proprietary compound, ilofotase alfa, is being developed as a potential enzyme replacement therapy for adult hypophosphatasia (HPP) patients.
| Website | http://www.am-pharma.com |
| Employees | 31 (8 on RocketReach) |
| Founded | 2002 |
| Phone | +31 30 228 9222 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology, Science and Engineering, Medical, Health Care, Pharmaceutical |
| Web Rank | 7 Million |
| Keywords | Biopharmaceutical, Clinical Development, Drug Development, Pharmaceutical Research, Biotechnology, Protein Therapeutics, Enzyme Therapy, Clinical Trials, New Drug Applications, Fda Submissions, Regulatory Affairs, Therapeutic Proteins, Biosimilar Development, Advanced Therapy Medicinal Products |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Sanofi, GSK, AstraZeneca, Bristol Myers Squibb +47 more (view full list) |
Looking for a particular AM-Pharma employee's phone or email?
AM-Pharma Questions
Juliane Bernholz is the CEO of AM-Pharma.
8 people are employed at AM-Pharma.
Top AM-Pharma Employees
-
Juliane Bernholz
Chief Executive Officer at AM-Pharma
Binningen, BL, CH13 -
Peter Verwayen
Vice President Finance at AM-Pharma
Almere, FL, NL2 -
Mark Altmeyer
Board Member at AM-Pharma
Boston, MA, US35+ -
Liesbeth Hof
Sr Director Project Management Office at AM-Pharma
Amsterdam, NH, NL3 -
Jacques Arend
Vice President Clinical Development and Chief Medical Officer at AM-Pharma
Leiden, South Holland, Netherlands2 -
Sahad Km
Sales Executive at AM-Pharma
Malappuram, KL, IN
Related Companies
G2Crowd Trusted
300K+
Plugin Users
